ESC Premium Access

Treatment and control of dyslipidemia among adults in northeastern China: results of the dyslipidemia international study (DYSIS)

Congress Presentation

About the speaker

Doctor Wen Zheng

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)
0 follower

3 more presentations in this session

Anti-proprotein convertase subtilisin-kexin type 9 monoclonal antibodies: effects on lipid profile and arterial stiffness


Evaluation of statin users, people with hypercholesterolemia, and cardiovascular disease patients in the Japan Medical Data Center claims database

Speaker: Doctor K. Monda (Thousand Oaks, US)


Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

Speaker: Professor A. Shek (Tashkent, UZ)


Access the full session

Poster session 1 - Treatment of dyslipidaemia

Speakers: Doctor W. Zheng, Doctor K. Monda, Professor A. Shek

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb